{
  "id": 16793986,
  "title": "IDSA: Earlier introduction of HPV vaccine improves initiation, completion by age 13",
  "url": "https://urgent.news/2026/10/27/idsa-earlier-introduction-of-hpv-vaccine-improves-initiation",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-27T20:00:18.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-10-idsa-earlier-introduction-hpv-vaccine.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Introducing the human papillomavirus (HPV) vaccine at ages 9 to 10 years rather than 11 to 12 years leads to a meaningful difference in initiation and completion of the vaccine series, including initiation and completion by age 13 years, according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 21 to 24 in Washington, D.C.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}